Style | Citing Format |
---|---|
MLA | Pishgahi M, et al.. "Association Between Serum Vitamin D Level and Echocardiographic Abnormalities in Patients With Thalassemia Major." Cardiovascular and Hematological Disorders - Drug Targets, vol. 20, no. 3, 2020, pp. 214-220. |
APA | Pishgahi M, Niroomand M, Bozorgmehr R, Ghanefard S, Mousavi F, Tabary M, Khaheshi I (2020). Association Between Serum Vitamin D Level and Echocardiographic Abnormalities in Patients With Thalassemia Major. Cardiovascular and Hematological Disorders - Drug Targets, 20(3), 214-220. |
Chicago | Pishgahi M, Niroomand M, Bozorgmehr R, Ghanefard S, Mousavi F, Tabary M, Khaheshi I. "Association Between Serum Vitamin D Level and Echocardiographic Abnormalities in Patients With Thalassemia Major." Cardiovascular and Hematological Disorders - Drug Targets 20, no. 3 (2020): 214-220. |
Harvard | Pishgahi M et al. (2020) 'Association Between Serum Vitamin D Level and Echocardiographic Abnormalities in Patients With Thalassemia Major', Cardiovascular and Hematological Disorders - Drug Targets, 20(3), pp. 214-220. |
Vancouver | Pishgahi M, Niroomand M, Bozorgmehr R, Ghanefard S, Mousavi F, Tabary M, et al.. Association Between Serum Vitamin D Level and Echocardiographic Abnormalities in Patients With Thalassemia Major. Cardiovascular and Hematological Disorders - Drug Targets. 2020;20(3):214-220. |
BibTex | @article{ author = {Pishgahi M and Niroomand M and Bozorgmehr R and Ghanefard S and Mousavi F and Tabary M and Khaheshi I}, title = {Association Between Serum Vitamin D Level and Echocardiographic Abnormalities in Patients With Thalassemia Major}, journal = {Cardiovascular and Hematological Disorders - Drug Targets}, volume = {20}, number = {3}, pages = {214-220}, year = {2020} } |
RIS | TY - JOUR AU - Pishgahi M AU - Niroomand M AU - Bozorgmehr R AU - Ghanefard S AU - Mousavi F AU - Tabary M AU - Khaheshi I TI - Association Between Serum Vitamin D Level and Echocardiographic Abnormalities in Patients With Thalassemia Major JO - Cardiovascular and Hematological Disorders - Drug Targets VL - 20 IS - 3 SP - 214 EP - 220 PY - 2020 ER - |